We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Becket Invest Plc | LSE:TAB | London | Ordinary Share | GB00BMWKKL25 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.20 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Blank Checks | 0 | -2.27M | -2.7622 | 0.00 | 9.84k |
RNS No 5069f THERAPEUTIC ANTIBODIES INC 4th September 1997 THERAPEUTIC ANTIBODIES INC ("the Company") DISCLOSURE OF MAJOR INTERESTS IN SHARES The Company has today been advised, in compliance with Part VI of the Companies Act 1985 (as amended), that as a result of recent purchases Prudential Portfolio Managers UK Limited are interested in 1,376,000 Common shares of US$ 0.001 each, in the Company, representing 6.42% of the issued share capital of the Company. Registered Holder details of holding Prudential Client (MSS Nominees Ltd PAC/A/C) 1,376,900 4th September 1997 END
1 Year Becket Invest Chart |
1 Month Becket Invest Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions